| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.71B | +11.3% |
| Cost of Revenue | $1.13B | +11.7% |
| Gross Profit | $587.2M | +10.7% |
| R&D Expense | $73.4M | +12.5% |
| SG&A Expense | $290.9M | +7.8% |
| Operating Income | $217.5M | +15.1% |
| Pre-tax Income | $186.1M | +15.4% |
| Income Tax | $36.5M | +10.3% |
| Net Income | $149.6M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106.4M | +11.6% |
| Accounts Receivable | $837.7M | +29.3% |
| Inventory | $407.2M | +2.3% |
| Current Assets | $1.42B | +17.1% |
| Total Assets | $2.24B | +15.8% |
| Current Liabilities | $696.9M | -14.4% |
| Long-term Debt | $471.6M | +242.9% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $97.6M | +211.5% |
| Capital Expenditures | $23.8M | +7.8% |
| Investing Cash Flow | -$117.9M | -213.1% |
| Financing Cash Flow | $30.8M | -78.6% |
| Free Cash Flow | $73.8M | +167.3% |
| +16.8% |
| EPS (Basic) | $8.93 | +18.3% |
| EPS (Diluted) | $8.71 | +18.0% |
| Total Liabilities |
| $1.29B |
| +20.3% |
| Stockholders' Equity | $951.1M | +10.1% |